Analysis of thrombocytopenia and risk factors associated with hematologic toxicities in neonates who received linezolid therapy.
- At: 2013 FIP Congress in Dublin (Ireland)
- Type: Poster
- By: TANG, Lian (Suzhou Municipal Hospital, Department of Pharmacy, Suzhou, China)
- Co-author(s): Shang, Erning (Suzhou Municipal Hospital, Suzhou, China)
Yu, Yanxia (Suzhou Municipal Hospital, Suzhou, China)
Weng, Xiaohong (Suzhou Municipal Hospital, Suzhou, China)
The use of linezolid in neonates for treating drug-resistant Gram-Positive infection is increasing. However, risk factors and variation of linezolid-associated thrombocytopenia are still unknown.
To characterize linezolid-associated thrombocytopenia and to analyze related factors associated with development of hematologic.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.